$450 Million is the total value of Eversept Partners, LP's 49 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 58.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $47,210,564 | -11.0% | 607,757 | -36.3% | 10.49% | +44.2% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $44,851,062 | +35.4% | 10,653,459 | +122.6% | 9.96% | +119.4% |
| TGTX | Sell | TG THERAPEUTICS INC | $27,384,311 | -43.8% | 1,023,330 | -59.1% | 6.08% | -8.9% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $24,846,137 | -23.8% | 161,004 | -26.9% | 5.52% | +23.5% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $24,331,304 | -13.6% | 240,904 | +3.5% | 5.41% | +40.0% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $21,573,139 | – | 2,394,355 | +100.0% | 4.79% | – |
| FATE | Buy | FATE THERAPEUTICS INC | $21,385,389 | +17.3% | 535,036 | +0.7% | 4.75% | +90.2% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $20,905,981 | -36.2% | 321,581 | -28.3% | 4.64% | +3.4% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $20,644,813 | -17.4% | 402,433 | -3.9% | 4.59% | +33.8% |
| ENSG | Sell | ENSIGN GROUP INC | $18,210,266 | +1.7% | 318,863 | -25.4% | 4.05% | +64.8% |
| HSKA | Sell | HESKA CORP | $15,685,086 | -39.9% | 158,772 | -43.3% | 3.48% | -2.7% |
| ZGNX | Sell | ZOGENIX INC | $15,513,771 | -43.0% | 865,241 | -14.1% | 3.45% | -7.6% |
| CTLT | New | CATALENT INC | $12,020,582 | – | 140,329 | +100.0% | 2.67% | – |
| OSUR | New | ORASURE TECHNOLOGIES INC | $11,444,814 | – | 940,412 | +100.0% | 2.54% | – |
| AMRX | Buy | AMNEAL PHARMACEUTICALS INC | $10,306,087 | +144.2% | 2,656,208 | +199.6% | 2.29% | +295.5% |
| FLDM | Buy | FLUIDIGM CORP DEL | $9,676,483 | +415.7% | 1,302,353 | +178.3% | 2.15% | +736.6% |
| QGEN | Buy | QIAGEN NV | $8,752,139 | +147.9% | 167,473 | +103.1% | 1.94% | +301.9% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $7,782,612 | +11.3% | 141,889 | +34.9% | 1.73% | +80.3% |
| DHR | Sell | DANAHER CORPORATION | $6,757,938 | -64.6% | 31,360 | -70.9% | 1.50% | -42.6% |
| MODN | Sell | MODEL N INC | $6,666,756 | -43.7% | 188,967 | -44.5% | 1.48% | -8.8% |
| HCA | Buy | HCA HEALTHCARE INC | $6,533,232 | +121.4% | 52,400 | +72.4% | 1.45% | +258.5% |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $6,422,206 | -27.9% | 435,995 | -20.5% | 1.43% | +16.8% |
| AMRN | Buy | AMARIN CORP PLCcall | $5,321,861 | -28.8% | 1,264,100 | +17.0% | 1.18% | +15.3% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $5,169,332 | +25.0% | 98,501 | -20.8% | 1.15% | +102.6% |
| MYL | New | MYLAN NV | $4,819,023 | – | 324,951 | +100.0% | 1.07% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $4,535,610 | – | 176,758 | +100.0% | 1.01% | – |
| AFMD | Buy | AFFIMED N V | $4,222,103 | -3.0% | 1,245,458 | +32.1% | 0.94% | +57.1% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $3,926,930 | -83.0% | 1,143,211 | -76.4% | 0.87% | -72.4% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $3,431,341 | -24.6% | 293,277 | -16.2% | 0.76% | +22.1% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $3,339,293 | -88.8% | 60,936 | -89.2% | 0.74% | -81.8% |
| MRSN | New | MERSANA THERAPEUTICS INC | $2,606,800 | – | 140,000 | +100.0% | 0.58% | – |
| SNY | SANOFIsponsored adr | $2,497,362 | -1.7% | 49,778 | 0.0% | 0.56% | +59.5% | |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $2,451,825 | -82.2% | 81,267 | -80.7% | 0.54% | -71.1% |
| GSK | Sell | GLAXOSMITHKLINE PLCsponsored adr | $2,453,292 | -73.5% | 64,372 | -71.7% | 0.54% | -57.1% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $2,231,826 | -75.9% | 150,494 | -78.9% | 0.50% | -60.9% |
| SESN | Sell | SESEN BIO INC | $2,183,754 | +51.6% | 1,559,824 | -22.0% | 0.48% | +146.2% |
| QDEL | New | QUIDEL CORP | $2,049,667 | – | 9,343 | +100.0% | 0.46% | – |
| PRTA | Buy | PROTHENA CORP PLC | $1,968,310 | +23.6% | 197,028 | +29.4% | 0.44% | +100.5% |
| OTIC | Sell | OTONOMY INC | $1,670,625 | -23.2% | 412,500 | -31.4% | 0.37% | +24.5% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $1,350,907 | +24.3% | 107,300 | +19.5% | 0.30% | +101.3% |
| CNCE | Sell | CONCERT PHARMACEUTICALS INC | $1,019,601 | -56.0% | 103,829 | -55.4% | 0.23% | -28.6% |
| LQDA | Sell | LIQUIDIA TECHNOLOGIES INC | $899,135 | -87.6% | 182,751 | -78.7% | 0.20% | -79.9% |
| LCI | New | LANNET INCcall | $636,437 | – | 122,500 | +100.0% | 0.14% | – |
| New | SOLID BIOSCIENCES INC | $623,259 | – | 307,024 | +100.0% | 0.14% | – | |
| TARA | Sell | PROTARA THERAPEUTICS INC | $611,097 | -55.0% | 36,310 | -21.6% | 0.14% | -26.9% |
| SCPH | Sell | SCPHARMACEUTICALS INC | $488,757 | -73.2% | 65,605 | -73.5% | 0.11% | -56.4% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $266,396 | -97.7% | 1,897 | -97.4% | 0.06% | -96.3% |
| Sell | TELIGENT INC NEW | $219,935 | -74.4% | 305,423 | -14.0% | 0.05% | -58.5% | |
| GOCO | New | GOHEALTH INC | $171,018 | – | 13,130 | +100.0% | 0.04% | – |
| ZGNX | Exit | ZOGENIX INCcall | $0 | – | -5,500 | -100.0% | -0.02% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -12,266 | -100.0% | -0.04% | – |
| EIGR | Exit | EIGER BIOPHARMACEUTICALS INC | $0 | – | -49,008 | -100.0% | -0.06% | – |
| OSMT | Exit | OSMOTICA PHARMACEUTICALS PLC | $0 | – | -79,037 | -100.0% | -0.07% | – |
| AL | Exit | AIR LEASE CORPput | $0 | – | -20,000 | -100.0% | -0.08% | – |
| BNR | Exit | BURNING ROCK BIOTECH LTDsponsored ads | $0 | – | -30,000 | -100.0% | -0.11% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -97,800 | -100.0% | -0.12% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -22,928 | -100.0% | -0.14% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -407,024 | -100.0% | -0.16% | – |
| XOMA | Exit | XOMA CORP DEL | $0 | – | -64,056 | -100.0% | -0.17% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -40,000 | -100.0% | -0.20% | – |
| CYCN | Exit | CYCLERION THERAPEUTICS INC | $0 | – | -247,663 | -100.0% | -0.20% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -492,272 | -100.0% | -0.20% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -78,029 | -100.0% | -0.28% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -81,700 | -100.0% | -0.28% | – |
| PNTG | Exit | PENNANT GROUP INC | $0 | – | -102,568 | -100.0% | -0.32% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -40,842 | -100.0% | -0.32% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -583,504 | -100.0% | -0.35% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -6,670 | -100.0% | -0.37% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INCput | $0 | – | -10,000 | -100.0% | -0.38% | – |
| VAPO | Exit | VAPOTHERM INC | $0 | – | -71,819 | -100.0% | -0.40% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -220,110 | -100.0% | -0.41% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -128,905 | -100.0% | -0.45% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -141,700 | -100.0% | -0.46% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -258,360 | -100.0% | -0.57% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -70,594 | -100.0% | -0.94% | – |
| PCRX | Exit | PACIRA BIOSCIENCES | $0 | – | -132,655 | -100.0% | -0.95% | – |
| XLV | Exit | SELECT SECTOR SPDR TRput | $0 | – | -80,000 | -100.0% | -1.10% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -760,551 | -100.0% | -2.15% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -340,000 | -100.0% | -14.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.